Results 301 to 310 of about 271,092 (363)

Using heated effluent from a 835 MWe nuclear power reactor for shellfish aquaculture [PDF]

Hess, C. T., Price, A. H., Smith, C. W.
core   +1 more source

Building confidence in models for complex barrier systems for radionuclides. [PDF]

Proc Natl Acad Sci U S A
Sarsenbayev D, Tournassat C, Steefel CI, Wainwright HM.   +3 more
europepmc   +1 more source

Nanoradiopharmaceuticals: Design Principles, Radiolabeling Strategies, and Biomedicine Applications. [PDF]

Pharmaceutics
Núñez-Salinas A, Parra-Garretón C, Acuña D, Peñaloza S, Günther G, Bollo S, Arriagada F, Morales J.   +7 more
europepmc   +1 more source

The use of radiopharmaceuticals in targeted cancer therapy: a narrative review. [PDF]

Int J Physiol Pathophysiol Pharmacol
Khalaji A, Rostampour M, Riahi F, Rafieezadeh D, Dormiani Tabatabaei SA, Fesharaki S, Tooyserkani SH.   +6 more
europepmc   +1 more source

Author's Response to Zuckier's Comments About the "Incoherence in the Brain Death Guideline Regarding Brain Blood Flow Testing". [PDF]

Linacre Q
Nguyen D, Zainer CM.
europepmc   +1 more source

National Monitoring for Radioactivity in Drinking Water - China, 2012-2024. [PDF]

China CDC Wkly
Yin L, Xie Y, Qian Y, Shi C, Ji Y.
europepmc   +1 more source

Preclinical Evaluation of PTK7-Targeted Radionuclide Therapy. [PDF]

Mol Cancer Ther
Lindland K, Westrøm S, Dragovic SM, Li RG, Malenge MM, Ho B, Juzeniene A, Bønsdorff TB.   +7 more
europepmc   +1 more source

Pathogen-specific Actinium-225 and Lutetium-177 labeled antibodies, as well as unbound radionuclide treatment show antimicrobial potential on a biofilm-associated implant infection - initial in vivo experience

Nurmohamed FRH, Allen KJ, Malo ME, Frank C, Duijvenbode JFFHv, Wildt Bvd, Poot AJ, Lam MGEH, Strijp JAG, Nikkels PG, Vogely HC, Weinans H, Dadachova E, Wal BCvd.   +13 more
europepmc   +1 more source